- Home
- GWRE vs HALO Comparison
GWRE vs HALO Comparison
Compare GWRE & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GWRE | HALO |
|---|---|---|
| Founded | 2001 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.8B |
| IPO Year | 2011 | 2001 |
Fundamental Metrics
Financial Performance| Metric | GWRE | HALO |
|---|---|---|
| Price | $143.25 | $70.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $251.31 | $78.18 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 06-02-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1257.14 | N/A |
| EPS | 1.06 | ★ 2.56 |
| Revenue | ★ $719,514,000.00 | $151,862,000.00 |
| Revenue This Year | $22.42 | $28.24 |
| Revenue Next Year | $15.76 | $12.56 |
| P/E Ratio | $135.00 | ★ $27.27 |
| Revenue Growth | ★ 8.84 | N/A |
| 52 Week Low | $115.57 | $47.50 |
| 52 Week High | $272.60 | $82.22 |
Technical Indicators
Market Signals| Indicator | GWRE | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 51.04 | 61.36 |
| Support Level | $142.86 | $67.94 |
| Resistance Level | $167.31 | $71.53 |
| Average True Range (ATR) | 7.93 | 1.87 |
| MACD | 0.40 | 0.78 |
| Stochastic Oscillator | 74.49 | 94.03 |
Price Performance
Historical ComparisonAbout GWRE Guidewire Software Inc.
Guidewire Software provides cloud-based software solutions for property and casualty insurers. The flagship product, InsuranceSuite is a system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a midmarket offering, as well as a variety of other add-on applications and services.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.